Health CanadaGeneral Alert
FIBRISTAL (ulipristal acetate tablets, 5 mg) - Voluntary Withdrawal in Canada du...
Published: September 30, 2020Recall ID: 61726Category: generalCountry: Canada
Reason for Recall / Hazard
Product safety
Product Description & Identification
FIBRISTAL (ulipristal acetate tablets, 5 mg) - Voluntary Withdrawal in Canada due to Risk of Drug-Induced Liver Injury
Additional Source Details
| Field | Value |
|---|---|
| N I D | 61726 |
| U R L | https://recalls-rappels.canada.ca/en/alert-recall/fibristal-ulipristal-acetate-tablets-5-mg-voluntary-withdrawal-canada-due-risk-drug |
| Issue | Product safety |
| Title | FIBRISTAL (ulipristal acetate tablets, 5 mg) - Voluntary Withdrawal in Canada due to Risk of Drug-Induced Liver Injury |
| Archived | 0 |
| Category | Drugs |
| Last updated | 2020-09-30 |
| Organization | Marketed health products |